Joshua T Davis

2PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 21, 2023
Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate Cancers.

Taraswi Mitra Ghosh, Suman Mazumder, Joshua Davis

|May 27, 2023
Extended Exposure Topotecan Significantly Improves Long-Term Drug Sensitivity by Decreasing Malignant Cell Heterogeneity and by Preventing Epithelial-Mesenchymal Transition.

Joshua T Davis, Taraswi Mitra Ghosh, Suman Mazumder

Pageof 1

Frequent Collaborators

2 joint publications

Robert D Arnold

2 joint publications

Amit Mitra

1 joint publications

Taraswi Mitra Ghosh

1 joint publications

Suman Mazumder